Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference8 articles.
1. Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution;Reig;J Hepatol,2016
2. Direct antiviral agents and risk for HCC early recurrence: much ado about nothing;Cammà;J Hepatol,2016
3. Buonfiglioli F, Conti F, Andreone P, Crespi C, Foschi FG, Lenzi M, et al. Development of Hepatocellular Carcinoma in HCV cirrhotic patients treated with direct acting antivirals, Abstracts of The International Liver Congress(TM) 2016–51th Annual meeting of the European Association for the Study of the Liver.
4. Lack of evidence of an effect of Direct Acting Antivirals on the recurrence of hepatocellular carcinoma: The ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CIRVIR and CO23 CUPILT cohorts);Pol;J Hepatol,2016
5. From non-A, non-B hepatitis to hepatitis C virus cure;Pawlotsky;J Hepatol,2015
Cited by 121 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01
2. Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC;BMC Cancer;2023-10-05
3. Frequency of De Novo Hepatocellular Carcinoma after Direct-acting Antiviral Therapy for Chronic Hepatitis C: A Prospective Follow-up;Euroasian Journal of Hepato-Gastroenterology;2023-03-10
4. Hepatocellular carcinoma after treatment of hepatitis C with direct-acting antivirals: a critical re-appraisal;Hepatoma Research;2023
5. Mitochondria and Cancer Recurrence after Liver Transplantation—What Is the Benefit of Machine Perfusion?;International Journal of Molecular Sciences;2022-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3